These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 32129378
1. A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R9) peptide for enhanced drug delivery. Zhang L, Jiang C, Zeng F, Zhou H, Li D, He X, Shen S, Yang X, Wang J. Biomater Sci; 2020 Apr 15; 8(8):2255-2263. PubMed ID: 32129378 [Abstract] [Full Text] [Related]
2. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Braunová A, Kostka L, Sivák L, Cuchalová L, Hvězdová Z, Laga R, Filippov S, Černoch P, Pechar M, Janoušková O, Šírová M, Etrych T. J Control Release; 2017 Jan 10; 245():41-51. PubMed ID: 27871991 [Abstract] [Full Text] [Related]
3. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bae Y, Nishiyama N, Kataoka K. Bioconjug Chem; 2007 Jan 10; 18(4):1131-9. PubMed ID: 17488066 [Abstract] [Full Text] [Related]
5. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration. Wan J, Geng S, Zhao H, Peng X, Zhou Q, Li H, He M, Zhao Y, Yang X, Xu H. J Control Release; 2016 Aug 10; 235():328-336. PubMed ID: 27282415 [Abstract] [Full Text] [Related]
6. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting. Tang B, Zaro JL, Shen Y, Chen Q, Yu Y, Sun P, Wang Y, Shen WC, Tu J, Sun C. J Control Release; 2018 Jun 10; 279():147-156. PubMed ID: 29653223 [Abstract] [Full Text] [Related]
7. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Chen WL, Li F, Tang Y, Yang SD, Li JZ, Yuan ZQ, Liu Y, Zhou XF, Liu C, Zhang XN. Int J Nanomedicine; 2017 Jun 10; 12():4241-4256. PubMed ID: 28652730 [Abstract] [Full Text] [Related]
8. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. Han X, Li Z, Sun J, Luo C, Li L, Liu Y, Du Y, Qiu S, Ai X, Wu C, Lian H, He Z. J Control Release; 2015 Jan 10; 197():29-40. PubMed ID: 25449802 [Abstract] [Full Text] [Related]
12. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W, Yi X, Liu X, Zhang Z, Fu Y, Gong T. J Control Release; 2016 Mar 10; 225():170-82. PubMed ID: 26826304 [Abstract] [Full Text] [Related]
14. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor. Li XX, Chen J, Shen JM, Zhuang R, Zhang SQ, Zhu ZY, Ma JB. Int J Pharm; 2018 Jul 10; 545(1-2):274-285. PubMed ID: 29733971 [Abstract] [Full Text] [Related]
15. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model. Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. Eur J Pharm Biopharm; 2015 Aug 10; 94():521-31. PubMed ID: 26170161 [Abstract] [Full Text] [Related]
17. Na+/K+ ATPase-targeted delivery to metastatic breast cancer models. Araste F, Abnous K, Hashemi M, Dehshahri A, Detampel P, Alibolandi M, Ramezani M. Eur J Pharm Sci; 2020 Feb 15; 143():105207. PubMed ID: 31870814 [Abstract] [Full Text] [Related]
18. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy. Mou Q, Ma Y, Zhu X, Yan D. J Control Release; 2016 May 28; 230():34-44. PubMed ID: 27040815 [Abstract] [Full Text] [Related]
19. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release. Xu M, Zhang CY, Wu J, Zhou H, Bai R, Shen Z, Deng F, Liu Y, Liu J. ACS Appl Mater Interfaces; 2019 Feb 13; 11(6):5701-5713. PubMed ID: 30644711 [Abstract] [Full Text] [Related]
20. Primary tumor and pre-metastatic niches co-targeting "peptides-lego" hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment. Xiong H, Du S, Zhang P, Jiang Z, Zhou J, Yao J. Biomater Sci; 2018 Sep 25; 6(10):2591-2604. PubMed ID: 30187035 [Abstract] [Full Text] [Related] Page: [Next] [New Search]